 David Partrick
Concepts (503)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 19 | 2022 | 321 | 2.200 |
Why?
| | Thoracoscopy | 9 | 2019 | 60 | 1.760 |
Why?
| | Appendicitis | 6 | 2018 | 150 | 1.290 |
Why?
| | Myasthenia Gravis | 2 | 2020 | 24 | 1.220 |
Why?
| | Spleen | 5 | 2019 | 508 | 1.200 |
Why?
| | Laparoscopy | 13 | 2015 | 481 | 1.190 |
Why?
| | Multiple Organ Failure | 14 | 2010 | 120 | 1.180 |
Why?
| | Trauma Centers | 19 | 2022 | 466 | 0.990 |
Why?
| | Funnel Chest | 3 | 2021 | 29 | 0.970 |
Why?
| | Appendectomy | 6 | 2018 | 90 | 0.940 |
Why?
| | Child | 72 | 2022 | 22707 | 0.850 |
Why?
| | Fundoplication | 7 | 2016 | 52 | 0.840 |
Why?
| | Brain Injuries | 6 | 2015 | 507 | 0.830 |
Why?
| | Gastrostomy | 7 | 2024 | 130 | 0.820 |
Why?
| | Postoperative Care | 2 | 2016 | 286 | 0.780 |
Why?
| | Injury Severity Score | 19 | 2022 | 599 | 0.770 |
Why?
| | Blood Transfusion | 4 | 2022 | 409 | 0.740 |
Why?
| | Length of Stay | 15 | 2019 | 1349 | 0.740 |
Why?
| | Child, Preschool | 52 | 2021 | 11853 | 0.740 |
Why?
| | Retrospective Studies | 54 | 2024 | 17291 | 0.720 |
Why?
| | Forecasting | 3 | 2019 | 390 | 0.690 |
Why?
| | Gastroesophageal Reflux | 5 | 2016 | 237 | 0.680 |
Why?
| | Analgesia, Epidural | 1 | 2021 | 39 | 0.680 |
Why?
| | Empyema | 1 | 2021 | 8 | 0.660 |
Why?
| | Mediastinal Neoplasms | 3 | 2014 | 53 | 0.640 |
Why?
| | Nerve Block | 1 | 2021 | 107 | 0.620 |
Why?
| | Thymectomy | 1 | 2019 | 15 | 0.620 |
Why?
| | Colonic Pouches | 1 | 2019 | 14 | 0.610 |
Why?
| | Wounds and Injuries | 11 | 2016 | 961 | 0.600 |
Why?
| | Neutrophils | 15 | 2002 | 1124 | 0.590 |
Why?
| | Phlebotomy | 1 | 2019 | 22 | 0.580 |
Why?
| | Colectomy | 1 | 2019 | 106 | 0.570 |
Why?
| | Adolescent | 56 | 2022 | 22529 | 0.560 |
Why?
| | Chest Tubes | 2 | 2019 | 34 | 0.560 |
Why?
| | Child Abuse | 6 | 2014 | 552 | 0.550 |
Why?
| | Infant | 36 | 2024 | 10077 | 0.540 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 148 | 0.530 |
Why?
| | Leukocyte Elastase | 8 | 2002 | 75 | 0.520 |
Why?
| | Liver | 4 | 2019 | 1896 | 0.520 |
Why?
| | Biopsy | 3 | 2016 | 1082 | 0.520 |
Why?
| | Intubation, Gastrointestinal | 5 | 2024 | 81 | 0.510 |
Why?
| | Delayed Diagnosis | 2 | 2015 | 100 | 0.510 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2015 | 10 | 0.500 |
Why?
| | Humans | 120 | 2024 | 145474 | 0.500 |
Why?
| | Platelet Activating Factor | 6 | 2000 | 45 | 0.480 |
Why?
| | Male | 73 | 2024 | 72842 | 0.480 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1149 | 0.460 |
Why?
| | Female | 74 | 2024 | 78844 | 0.450 |
Why?
| | Digestive System Surgical Procedures | 3 | 2014 | 112 | 0.450 |
Why?
| | Pulmonary Surgical Procedures | 1 | 2015 | 7 | 0.450 |
Why?
| | Minimally Invasive Surgical Procedures | 5 | 2014 | 189 | 0.450 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2019 | 53 | 0.440 |
Why?
| | Surgery Department, Hospital | 1 | 2015 | 22 | 0.440 |
Why?
| | Abdominal Abscess | 2 | 2012 | 26 | 0.440 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2015 | 19 | 0.440 |
Why?
| | Angiography | 2 | 2015 | 208 | 0.430 |
Why?
| | Enteral Nutrition | 5 | 2024 | 217 | 0.430 |
Why?
| | Ileal Diseases | 1 | 2014 | 14 | 0.430 |
Why?
| | Superoxides | 12 | 2002 | 198 | 0.420 |
Why?
| | Accidents | 1 | 2014 | 46 | 0.420 |
Why?
| | Embolization, Therapeutic | 2 | 2015 | 242 | 0.390 |
Why?
| | Hemoglobins | 5 | 2022 | 386 | 0.380 |
Why?
| | Postoperative Complications | 10 | 2022 | 2970 | 0.380 |
Why?
| | Device Removal | 1 | 2014 | 142 | 0.380 |
Why?
| | Phospholipases A | 4 | 2001 | 97 | 0.360 |
Why?
| | Pancreatic Elastase | 6 | 2001 | 53 | 0.350 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 337 | 0.350 |
Why?
| | Abdominal Injuries | 4 | 2015 | 130 | 0.350 |
Why?
| | Tomography, X-Ray Computed | 8 | 2021 | 2769 | 0.350 |
Why?
| | Registries | 8 | 2014 | 2406 | 0.350 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2015 | 291 | 0.350 |
Why?
| | Electroencephalography | 1 | 2015 | 561 | 0.340 |
Why?
| | Neutrophil Activation | 4 | 2000 | 84 | 0.340 |
Why?
| | Crohn Disease | 1 | 2014 | 260 | 0.330 |
Why?
| | Anesthesia | 1 | 2014 | 256 | 0.330 |
Why?
| | Intestinal Volvulus | 2 | 2024 | 23 | 0.320 |
Why?
| | Colorado | 20 | 2018 | 4553 | 0.320 |
Why?
| | Multiple Trauma | 8 | 2005 | 121 | 0.320 |
Why?
| | Disease Management | 1 | 2014 | 653 | 0.310 |
Why?
| | Intercellular Adhesion Molecule-1 | 4 | 2001 | 132 | 0.310 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2010 | 79 | 0.310 |
Why?
| | Suture Techniques | 1 | 2010 | 137 | 0.300 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 225 | 0.300 |
Why?
| | Wounds, Gunshot | 1 | 2013 | 258 | 0.300 |
Why?
| | Shock, Hemorrhagic | 3 | 2016 | 199 | 0.290 |
Why?
| | Neoplasms | 2 | 2015 | 2906 | 0.290 |
Why?
| | Preoperative Care | 3 | 2024 | 380 | 0.290 |
Why?
| | Hypotension | 2 | 2016 | 127 | 0.290 |
Why?
| | Treatment Outcome | 19 | 2016 | 11772 | 0.280 |
Why?
| | Craniocerebral Trauma | 4 | 2014 | 178 | 0.270 |
Why?
| | Head Injuries, Closed | 2 | 2011 | 49 | 0.270 |
Why?
| | Leukotriene B4 | 2 | 1998 | 36 | 0.270 |
Why?
| | Laparotomy | 5 | 2015 | 113 | 0.260 |
Why?
| | Thoracic Surgical Procedures | 2 | 2005 | 94 | 0.250 |
Why?
| | Lung | 4 | 2015 | 4106 | 0.250 |
Why?
| | Infant, Newborn | 15 | 2024 | 6447 | 0.240 |
Why?
| | Risk Factors | 16 | 2015 | 10885 | 0.240 |
Why?
| | Hemorrhage | 2 | 2016 | 822 | 0.240 |
Why?
| | Endoscopy | 2 | 2007 | 317 | 0.240 |
Why?
| | Sternum | 1 | 2005 | 27 | 0.230 |
Why?
| | Glasgow Coma Scale | 3 | 2015 | 218 | 0.230 |
Why?
| | Mediastinum | 1 | 2005 | 23 | 0.230 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1923 | 0.230 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2930 | 0.220 |
Why?
| | Intraoperative Period | 2 | 2015 | 69 | 0.220 |
Why?
| | Hematocrit | 2 | 2015 | 108 | 0.210 |
Why?
| | Prostheses and Implants | 1 | 2005 | 137 | 0.210 |
Why?
| | Follow-Up Studies | 9 | 2019 | 5423 | 0.210 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.210 |
Why?
| | Age Factors | 9 | 2016 | 3342 | 0.200 |
Why?
| | Triage | 2 | 2014 | 250 | 0.200 |
Why?
| | Inflammation Mediators | 3 | 2004 | 506 | 0.200 |
Why?
| | Drainage | 3 | 2019 | 185 | 0.190 |
Why?
| | CD18 Antigens | 5 | 2002 | 21 | 0.190 |
Why?
| | Splenectomy | 3 | 2015 | 61 | 0.190 |
Why?
| | Macrophage-1 Antigen | 4 | 2002 | 26 | 0.190 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 25 | 0.180 |
Why?
| | Incidence | 9 | 2018 | 2923 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2000 | 288 | 0.170 |
Why?
| | Cardiopulmonary Bypass | 3 | 2003 | 218 | 0.170 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2015 | 221 | 0.170 |
Why?
| | Pulmonary Blastoma | 1 | 2021 | 8 | 0.170 |
Why?
| | Ribonuclease III | 1 | 2021 | 43 | 0.160 |
Why?
| | DEAD-box RNA Helicases | 1 | 2021 | 83 | 0.160 |
Why?
| | Thoracic Injuries | 2 | 2005 | 71 | 0.160 |
Why?
| | Accidents, Traffic | 3 | 2011 | 193 | 0.160 |
Why?
| | Joint Dislocations | 1 | 2000 | 60 | 0.160 |
Why?
| | Ultrasonography, Interventional | 1 | 2021 | 165 | 0.150 |
Why?
| | Time Factors | 12 | 2024 | 7123 | 0.150 |
Why?
| | Empyema, Pleural | 1 | 2019 | 13 | 0.150 |
Why?
| | Proctocolectomy, Restorative | 1 | 2019 | 23 | 0.150 |
Why?
| | Neuroblastoma | 2 | 2014 | 174 | 0.150 |
Why?
| | Adult | 25 | 2022 | 40777 | 0.150 |
Why?
| | Lung Neoplasms | 3 | 2021 | 2664 | 0.150 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 558 | 0.150 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2010 | 95 | 0.150 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 113 | 0.140 |
Why?
| | Fibrinolytic Agents | 2 | 2019 | 297 | 0.140 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 168 | 0.140 |
Why?
| | Accidents, Home | 1 | 1998 | 33 | 0.140 |
Why?
| | Diagnosis, Differential | 4 | 2014 | 1508 | 0.140 |
Why?
| | Cause of Death | 2 | 2014 | 470 | 0.140 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.140 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1127 | 0.140 |
Why?
| | Thoracotomy | 3 | 2019 | 85 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 1998 | 43 | 0.130 |
Why?
| | Endothelial Cells | 2 | 2015 | 874 | 0.130 |
Why?
| | Hernia, Inguinal | 1 | 1998 | 43 | 0.130 |
Why?
| | Molsidomine | 1 | 1997 | 5 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 610 | 0.130 |
Why?
| | Age Distribution | 5 | 2003 | 403 | 0.130 |
Why?
| | Cyclic GMP | 1 | 1997 | 90 | 0.130 |
Why?
| | Prognosis | 7 | 2015 | 4316 | 0.130 |
Why?
| | Interleukin-8 | 2 | 2003 | 269 | 0.120 |
Why?
| | Patient Readmission | 3 | 2024 | 769 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 910 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2021 | 413 | 0.120 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 65 | 0.120 |
Why?
| | Sex Distribution | 4 | 2002 | 387 | 0.120 |
Why?
| | Kidney | 2 | 2004 | 1497 | 0.120 |
Why?
| | Rectum | 2 | 2010 | 182 | 0.120 |
Why?
| | Injections, Intravenous | 1 | 2016 | 197 | 0.120 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 12 | 0.110 |
Why?
| | Trauma Severity Indices | 5 | 2013 | 115 | 0.110 |
Why?
| | Blood Substitutes | 2 | 2009 | 27 | 0.110 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1266 | 0.110 |
Why?
| | Young Adult | 6 | 2022 | 14218 | 0.110 |
Why?
| | Anesthetics | 1 | 2016 | 99 | 0.110 |
Why?
| | Analysis of Variance | 5 | 2004 | 1300 | 0.110 |
Why?
| | Shock | 1 | 2016 | 110 | 0.110 |
Why?
| | Recovery of Function | 2 | 2015 | 716 | 0.110 |
Why?
| | Nitric Oxide | 2 | 2013 | 892 | 0.110 |
Why?
| | Interleukin-6 | 3 | 2004 | 776 | 0.110 |
Why?
| | Rehydration Solutions | 1 | 2014 | 9 | 0.110 |
Why?
| | Radiography, Thoracic | 2 | 2014 | 172 | 0.110 |
Why?
| | Isotonic Solutions | 1 | 2014 | 42 | 0.110 |
Why?
| | Pneumothorax | 3 | 2021 | 52 | 0.110 |
Why?
| | Shock, Traumatic | 1 | 2014 | 14 | 0.110 |
Why?
| | Neurilemmoma | 1 | 2014 | 25 | 0.110 |
Why?
| | Sentinel Lymph Node Biopsy | 2 | 2005 | 117 | 0.100 |
Why?
| | Heart Rate | 2 | 2015 | 855 | 0.100 |
Why?
| | Child Advocacy | 1 | 2014 | 31 | 0.100 |
Why?
| | Specialties, Surgical | 2 | 2014 | 82 | 0.100 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 89 | 0.100 |
Why?
| | Resuscitation | 3 | 2003 | 310 | 0.100 |
Why?
| | Hypertension, Pulmonary | 2 | 2016 | 1957 | 0.100 |
Why?
| | Clinical Protocols | 1 | 2015 | 280 | 0.100 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2014 | 98 | 0.100 |
Why?
| | Foreign Bodies | 1 | 2014 | 110 | 0.100 |
Why?
| | Administration, Oral | 1 | 2016 | 866 | 0.100 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2013 | 66 | 0.100 |
Why?
| | Bronchiectasis | 1 | 2014 | 115 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 102 | 0.100 |
Why?
| | Bronchi | 1 | 2014 | 263 | 0.090 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2015 | 270 | 0.090 |
Why?
| | Lymphoma | 1 | 2014 | 237 | 0.090 |
Why?
| | Referral and Consultation | 2 | 2018 | 867 | 0.090 |
Why?
| | Risk Assessment | 4 | 2015 | 3747 | 0.090 |
Why?
| | Blood Pressure | 3 | 2015 | 1779 | 0.090 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2015 | 2507 | 0.090 |
Why?
| | Prospective Studies | 7 | 2006 | 8057 | 0.090 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 688 | 0.090 |
Why?
| | Survival Rate | 5 | 2014 | 2090 | 0.080 |
Why?
| | Hematologic Diseases | 1 | 2011 | 66 | 0.080 |
Why?
| | Thyroidectomy | 1 | 2011 | 92 | 0.080 |
Why?
| | Prader-Willi Syndrome | 1 | 2010 | 33 | 0.080 |
Why?
| | Rectal Prolapse | 1 | 2010 | 24 | 0.080 |
Why?
| | Mortality | 1 | 2013 | 378 | 0.080 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2010 | 5 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 166 | 0.080 |
Why?
| | Liver Cirrhosis, Biliary | 1 | 2010 | 15 | 0.080 |
Why?
| | Endocrinology | 1 | 2011 | 77 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2010 | 29 | 0.080 |
Why?
| | Platelet Count | 1 | 2010 | 94 | 0.080 |
Why?
| | Intestinal Diseases | 1 | 2010 | 43 | 0.080 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2013 | 372 | 0.070 |
Why?
| | Lipopolysaccharides | 3 | 2009 | 858 | 0.070 |
Why?
| | Hernia, Diaphragmatic | 2 | 2013 | 67 | 0.070 |
Why?
| | Contrast Media | 3 | 2024 | 497 | 0.070 |
Why?
| | Coronary Artery Bypass | 2 | 2003 | 268 | 0.070 |
Why?
| | Patient Discharge | 1 | 2016 | 992 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 289 | 0.070 |
Why?
| | Parenteral Nutrition | 1 | 2010 | 102 | 0.070 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 76 | 0.070 |
Why?
| | Perioperative Care | 1 | 2011 | 231 | 0.070 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2010 | 143 | 0.070 |
Why?
| | Hirschsprung Disease | 1 | 2010 | 92 | 0.070 |
Why?
| | General Surgery | 1 | 2011 | 206 | 0.070 |
Why?
| | Melanoma | 2 | 2005 | 759 | 0.070 |
Why?
| | Interleukin-10 | 3 | 2004 | 309 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 329 | 0.070 |
Why?
| | Cellulitis | 1 | 2007 | 54 | 0.070 |
Why?
| | Skin Neoplasms | 2 | 2005 | 849 | 0.070 |
Why?
| | NADPH Oxidases | 2 | 1999 | 122 | 0.060 |
Why?
| | Ultrasonography | 2 | 2003 | 785 | 0.060 |
Why?
| | Acute Lung Injury | 1 | 2010 | 305 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2013 | 776 | 0.060 |
Why?
| | Pediatrics | 2 | 2014 | 1121 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2000 | 762 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2004 | 1217 | 0.060 |
Why?
| | Emergency Medical Services | 1 | 2013 | 684 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2014 | 928 | 0.060 |
Why?
| | Mammary Arteries | 1 | 2005 | 9 | 0.060 |
Why?
| | Viscera | 1 | 2005 | 17 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 44 | 0.060 |
Why?
| | Pylorus | 1 | 2005 | 17 | 0.060 |
Why?
| | United States | 6 | 2014 | 16098 | 0.060 |
Why?
| | Foreign-Body Migration | 1 | 2005 | 33 | 0.060 |
Why?
| | Abdominal Pain | 1 | 2006 | 149 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 14 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 696 | 0.060 |
Why?
| | Nevus, Pigmented | 1 | 2005 | 35 | 0.050 |
Why?
| | Renal Veins | 1 | 2004 | 18 | 0.050 |
Why?
| | Patient Selection | 2 | 2010 | 738 | 0.050 |
Why?
| | Reactive Oxygen Species | 2 | 2015 | 611 | 0.050 |
Why?
| | Renal Artery | 1 | 2004 | 43 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2016 | 1997 | 0.050 |
Why?
| | Asymptomatic Diseases | 1 | 2024 | 104 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2010 | 835 | 0.050 |
Why?
| | Radiation Exposure | 1 | 2024 | 63 | 0.050 |
Why?
| | Phospholipases A2 | 2 | 2001 | 79 | 0.050 |
Why?
| | Diaphragm | 1 | 2004 | 48 | 0.050 |
Why?
| | Interleukin-11 | 2 | 2003 | 10 | 0.050 |
Why?
| | Hernia, Umbilical | 1 | 2003 | 21 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 6 | 0.050 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2001 | 224 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 163 | 0.050 |
Why?
| | Predictive Value of Tests | 3 | 2013 | 2121 | 0.050 |
Why?
| | Cytokines | 2 | 2009 | 2067 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 59 | 0.050 |
Why?
| | Appendix | 1 | 2003 | 31 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 33 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 180 | 0.050 |
Why?
| | Stroke | 1 | 2011 | 1270 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1999 | 149 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 102 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 116 | 0.050 |
Why?
| | Infant, Premature, Diseases | 1 | 2003 | 113 | 0.050 |
Why?
| | Recurrence | 1 | 2005 | 1138 | 0.040 |
Why?
| | Middle Aged | 10 | 2014 | 36215 | 0.040 |
Why?
| | Pulmonary Edema | 1 | 2002 | 105 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2002 | 185 | 0.040 |
Why?
| | Peritonitis | 1 | 2002 | 83 | 0.040 |
Why?
| | Diagnostic Errors | 1 | 2003 | 178 | 0.040 |
Why?
| | Catheterization, Central Venous | 1 | 2003 | 123 | 0.040 |
Why?
| | Sheep | 2 | 2015 | 876 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2003 | 285 | 0.040 |
Why?
| | Cardiology | 1 | 2024 | 362 | 0.040 |
Why?
| | Bites and Stings | 1 | 2001 | 30 | 0.040 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 199 | 0.040 |
Why?
| | Pyridoxal Phosphate | 1 | 2001 | 20 | 0.040 |
Why?
| | Kidney Diseases, Cystic | 1 | 2021 | 24 | 0.040 |
Why?
| | Esophageal Achalasia | 1 | 2001 | 29 | 0.040 |
Why?
| | Wounds, Penetrating | 1 | 2001 | 72 | 0.040 |
Why?
| | Critical Care | 2 | 2003 | 702 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 961 | 0.040 |
Why?
| | Decision Support Techniques | 2 | 2015 | 477 | 0.040 |
Why?
| | CD11 Antigens | 2 | 1998 | 30 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 381 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 2002 | 1048 | 0.040 |
Why?
| | CHO Cells | 2 | 1998 | 169 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 176 | 0.040 |
Why?
| | Cricetinae | 2 | 1998 | 305 | 0.040 |
Why?
| | Sialoglycoproteins | 1 | 1999 | 157 | 0.040 |
Why?
| | NF-kappa B | 1 | 2003 | 666 | 0.040 |
Why?
| | Hospital Mortality | 2 | 2014 | 1038 | 0.040 |
Why?
| | Esophagoscopy | 1 | 2001 | 223 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1999 | 162 | 0.040 |
Why?
| | Inflammation | 4 | 2001 | 2878 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 322 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1082 | 0.040 |
Why?
| | Logistic Models | 2 | 2015 | 2134 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 1999 | 211 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1547 | 0.040 |
Why?
| | Vas Deferens | 1 | 1998 | 11 | 0.040 |
Why?
| | Phosphatidic Acids | 1 | 1998 | 8 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 1999 | 253 | 0.030 |
Why?
| | Receptors, Peptide | 1 | 1998 | 18 | 0.030 |
Why?
| | Antibodies, Monoclonal | 3 | 2010 | 1505 | 0.030 |
Why?
| | Signal Transduction | 3 | 2015 | 5216 | 0.030 |
Why?
| | Blood Bactericidal Activity | 1 | 1998 | 38 | 0.030 |
Why?
| | Alprostadil | 1 | 1998 | 29 | 0.030 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2002 | 338 | 0.030 |
Why?
| | Endopeptidases | 1 | 1998 | 80 | 0.030 |
Why?
| | Myocardium | 1 | 2003 | 934 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1998 | 168 | 0.030 |
Why?
| | Animals | 8 | 2015 | 38030 | 0.030 |
Why?
| | Cell Physiological Phenomena | 1 | 1997 | 17 | 0.030 |
Why?
| | Dibutyryl Cyclic GMP | 1 | 1997 | 2 | 0.030 |
Why?
| | Calcium | 2 | 2001 | 1190 | 0.030 |
Why?
| | Respiratory Burst | 1 | 1997 | 19 | 0.030 |
Why?
| | Transfection | 2 | 1998 | 926 | 0.030 |
Why?
| | Pneumonia | 1 | 2003 | 636 | 0.030 |
Why?
| | Heart Arrest | 1 | 2002 | 410 | 0.030 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 1998 | 60 | 0.030 |
Why?
| | Hospitalization | 3 | 2014 | 2460 | 0.030 |
Why?
| | Femoral Fractures | 1 | 1998 | 84 | 0.030 |
Why?
| | Cells, Cultured | 4 | 2013 | 4148 | 0.030 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 1997 | 24 | 0.030 |
Why?
| | Isoproterenol | 1 | 1997 | 96 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1997 | 92 | 0.030 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1997 | 58 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 1998 | 208 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Insufflation | 1 | 1996 | 14 | 0.030 |
Why?
| | North Carolina | 1 | 2016 | 129 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1997 | 387 | 0.030 |
Why?
| | Cell Death | 1 | 1998 | 382 | 0.030 |
Why?
| | Aged | 5 | 2014 | 26153 | 0.030 |
Why?
| | Bone Marrow | 1 | 1998 | 306 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1996 | 185 | 0.030 |
Why?
| | Endothelium, Vascular | 3 | 2013 | 956 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 852 | 0.030 |
Why?
| | Solubility | 1 | 1996 | 240 | 0.030 |
Why?
| | Osteosarcoma | 1 | 1996 | 82 | 0.030 |
Why?
| | Awards and Prizes | 1 | 1996 | 71 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 664 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 351 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 1996 | 227 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 134 | 0.030 |
Why?
| | Hypoxia | 1 | 2002 | 1199 | 0.030 |
Why?
| | Models, Biological | 2 | 2002 | 1764 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 247 | 0.030 |
Why?
| | Craniotomy | 1 | 2014 | 84 | 0.030 |
Why?
| | Kinetics | 1 | 1997 | 1567 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 767 | 0.030 |
Why?
| | Lymphatic Metastasis | 2 | 2005 | 331 | 0.030 |
Why?
| | Needs Assessment | 1 | 2016 | 402 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 325 | 0.020 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 56 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4560 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2013 | 73 | 0.020 |
Why?
| | Motor Skills | 1 | 2014 | 104 | 0.020 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 130 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2014 | 155 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2015 | 181 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 153 | 0.020 |
Why?
| | Ethanol | 1 | 1998 | 631 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 308 | 0.020 |
Why?
| | Flow Cytometry | 1 | 1996 | 1162 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 637 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2378 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2013 | 192 | 0.020 |
Why?
| | Infant, Premature | 1 | 2016 | 619 | 0.020 |
Why?
| | Up-Regulation | 3 | 2001 | 847 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 26 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 39 | 0.020 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 244 | 0.020 |
Why?
| | Reoperation | 2 | 2006 | 633 | 0.020 |
Why?
| | Neoplasm Staging | 2 | 2006 | 1471 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 382 | 0.020 |
Why?
| | Health Care Costs | 1 | 2014 | 425 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 44 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 552 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 47 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 176 | 0.020 |
Why?
| | Sulfonamides | 1 | 2015 | 583 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 57 | 0.020 |
Why?
| | Heparin | 1 | 2011 | 247 | 0.020 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 2 | 2002 | 38 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 428 | 0.020 |
Why?
| | Rho(D) Immune Globulin | 1 | 2010 | 6 | 0.020 |
Why?
| | Antigens, CD20 | 1 | 2010 | 34 | 0.020 |
Why?
| | Parenteral Nutrition, Total | 1 | 2010 | 30 | 0.020 |
Why?
| | Cell Line | 2 | 2009 | 2823 | 0.020 |
Why?
| | Lung Diseases | 1 | 2016 | 780 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 200 | 0.020 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 95 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1374 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2014 | 713 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 66 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2011 | 536 | 0.020 |
Why?
| | Protoporphyrins | 1 | 2009 | 16 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 88 | 0.020 |
Why?
| | Steroids | 1 | 2010 | 160 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2010 | 133 | 0.020 |
Why?
| | Treatment Failure | 1 | 2010 | 360 | 0.020 |
Why?
| | Rituximab | 1 | 2010 | 210 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 117 | 0.020 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 86 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 174 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1001 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 561 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 462 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 339 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 881 | 0.020 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 223 | 0.020 |
Why?
| | Intestinal Perforation | 1 | 2007 | 46 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2011 | 499 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3413 | 0.020 |
Why?
| | Pancreas | 1 | 2010 | 341 | 0.020 |
Why?
| | Comorbidity | 2 | 2003 | 1661 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 350 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 289 | 0.020 |
Why?
| | Anticoagulants | 1 | 2011 | 748 | 0.010 |
Why?
| | Tissue Adhesions | 1 | 2006 | 34 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2009 | 588 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 820 | 0.010 |
Why?
| | Equipment Failure | 1 | 2006 | 115 | 0.010 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 120 | 0.010 |
Why?
| | Databases, Factual | 1 | 2011 | 1490 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 111 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 15 | 0.010 |
Why?
| | Cohort Studies | 1 | 2015 | 6013 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 91 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 15 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 16 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 42 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 11 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 57 | 0.010 |
Why?
| | E-Selectin | 1 | 2003 | 61 | 0.010 |
Why?
| | Monokines | 1 | 2002 | 21 | 0.010 |
Why?
| | Infant, Low Birth Weight | 1 | 2003 | 156 | 0.010 |
Why?
| | Chemokine CXCL2 | 1 | 2002 | 41 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 39 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 515 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2864 | 0.010 |
Why?
| | Safety | 1 | 2004 | 358 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 172 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 119 | 0.010 |
Why?
| | Probability | 1 | 2002 | 307 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2003 | 181 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2002 | 316 | 0.010 |
Why?
| | Egtazic Acid | 1 | 2001 | 37 | 0.010 |
Why?
| | Barium Sulfate | 1 | 2001 | 14 | 0.010 |
Why?
| | Umbilical Veins | 1 | 2001 | 58 | 0.010 |
Why?
| | Spine | 1 | 2003 | 182 | 0.010 |
Why?
| | Chelating Agents | 1 | 2001 | 76 | 0.010 |
Why?
| | Manometry | 1 | 2001 | 98 | 0.010 |
Why?
| | Cytosol | 1 | 2001 | 213 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 203 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2001 | 123 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 466 | 0.010 |
Why?
| | Dogs | 1 | 2001 | 458 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 891 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 135 | 0.010 |
Why?
| | Acute Disease | 1 | 2002 | 1036 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 264 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2865 | 0.010 |
Why?
| | Receptors, Formyl Peptide | 1 | 1998 | 17 | 0.010 |
Why?
| | Spinal Cord Injuries | 1 | 2002 | 234 | 0.010 |
Why?
| | Protease Inhibitors | 1 | 1998 | 102 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1998 | 414 | 0.010 |
Why?
| | Colforsin | 1 | 1997 | 47 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 206 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 2105 | 0.010 |
Why?
| | Alcoholic Intoxication | 1 | 1998 | 76 | 0.010 |
Why?
| | Body Weight | 1 | 2001 | 971 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1998 | 451 | 0.010 |
Why?
| | Down-Regulation | 1 | 1997 | 618 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2597 | 0.010 |
Why?
| | Critical Illness | 1 | 2001 | 900 | 0.010 |
Why?
| | Reperfusion Injury | 1 | 1997 | 293 | 0.010 |
Why?
| | Trachea | 1 | 1996 | 258 | 0.010 |
Why?
| | Rats | 1 | 2002 | 5584 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 1997 | 560 | 0.010 |
Why?
| | Apoptosis | 1 | 2002 | 2440 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 8333 | 0.010 |
Why?
| | Mice | 1 | 2009 | 18329 | 0.010 |
Why?
| | Biomarkers | 1 | 2003 | 4295 | 0.010 |
Why?
| | Macrophages | 1 | 1997 | 1507 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 2002 | 2381 | 0.000 |
Why?
|
|
Partrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|